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Th17 cells are a subset of T cells that produce 
IL-17A, IL-17F, IL-6, and TNF (Cua et al., 
2003;  Langrish  et  al.,  2005;  Veldhoen  and 
Stockinger, 2006; Ivanov et al., 2006; Weaver 
et al., 2006; Bettelli et al., 2006; Sutton et al., 
2006). They are involved primarily in mediat-
ing inflammatory diseases and immune defense 
against extracellular bacteria. Th17 cells can be 
generated from naive precursors in the pres-
ence of TGF- and IL-6 or IL-21 (Bettelli et al., 
2006),  which  can  be  further  augmented  by 
TNF or IL-1 (inflammatory cytokines that in-
hibit Th1 and Th2 cell differentiation; Sutton 
et al., 2006; Chung et al., 2009). Developments 
of Th1, Th2, and regulatory T cells (T reg cells) 
are  specified  by  transcription  factors  such  as 
Tbet, GATA3, and Foxp3, respectively, whereas 
that of Th17 cells appears to depend on the 
retinoid-related orphan receptor (ROR) T, 
ROR,  and  signal  transducer  and  activator   
of transcription (STAT3; Ivanov et al., 2006; 
Yang et al., 2007, 2008).
RORT and its isoform ROR are en-
coded by a single gene called Rorg (also known 
as Rorc). Both isoforms use the last 9 exons (ex-
ons 3–11) of the Rorg gene, but the other exons 
used by them are different. As a consequence, 
the  RORT  mRNA  differs  from  that  of 
ROR in the first 100 nt, which translate into 
distinct  N-terminal  aa  sequences  (He  et  al.,   
1998; Villey et al., 1999). Nonetheless, both 
isoforms have the same DNA-binding domain 
and  ligand-binding  domain.  In  fact,  ROR 
contains all but three N-terminal aa of ROR 
T, which has a total of 495 aa (ROR has 516 aa). 
The two isoforms differ in their expression 
patterns.  RORT  is  preferentially  expressed   
in the thymus and differentiated Th17 cells, 
whereas  ROR  is  expressed  in  a  variety  of   
organ systems, including muscle, kidney, and 
liver, although its expression in Th17 cells has 
not been examined. Whether the two isoforms 
are generated as a result of alternative usage of 
different promoters or alternative splicing of a 
common pre-mRNA is not clear. RORT is 
considered to be a lineage-specific marker of 
Th17 cells. It is induced during Th17 differen-
tiation, and can directly activate genes encoding 
IL-17A and IL-17F. RORT-deficient T cells 
are  significantly  compromised  in  their Th17 
differentiation program (Ivanov et al., 2006). 
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The Th17 cells use the retinoid-related orphan receptor- (Rorg or Rorc) to specify their 
differentiation and lineage-specific function. However, how Rorg is switched on during 
Th17 differentiation is unknown. We report here that c-Rel and RelA/p65 transcription 
factors drive Th17 differentiation by binding to and activating two distinct Rorg promoters 
that control RORT and ROR expression, respectively. Similar to RORT, ROR is selec-
tively expressed in Th17 cells and is effective in specifying the Th17 phenotype. T cells 
deficient in c-Rel or RelA are significantly compromised in Th17 differentiation, and  
c-Rel–deficient mice are defective in Th17 responses. Thus, Th17 immunity is controlled  
by a Rel–ROR–RORT axis, and strategies targeting Rel/NF-B can be effective for  
controlling Th17 cell–mediated diseases.
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Whether and to what degree the ROR isoform plays a role 
in Th17 differentiation is unknown.
The mammalian Rel/NF-B family consists of five mem-
bers: c-Rel, p65 (or RelA), RelB, NF-B1 (p50/p105), and 
NF-B2 (p52/p100; Beg and Baltimore, 1996; Barnes and 
Karin, 1997). Unlike other members that are constitutively 
expressed in multiple cell types, c-Rel is expressed primarily 
in lymphoid tissues by lymphoid and myeloid cells (Brownell 
et  al.,  1987;  Simek  and  Rice,  1988;  Wang  et  al.,  1997;   
Huguet et al., 1998; Gerondakis et al., 1998). c-Rel–deficient 
mice do not suffer from developmental problems or infec-
tious diseases, and c-Rel–deficient T cells are competent in 
survival but are significantly compromised in TCR-induced 
gene expression (Köntgen et al., 1995; Tumang et al., 1998; 
Hilliard et al., 2002; Bunting et al., 2007). We report here 
that c-Rel and p65 play a crucial role in activating the Rorg 
gene that is required for initiating Th17 differentiation.
RESULTS
T cells deficient in c-Rel or RelA/p65 are significantly 
compromised in Th17 differentiation and Th17 responses
To determine the potential roles of c-Rel in Th17 immunity, 
we compared WT and c-Rel–deficient T cells for their Th17 
responses. We found that CD4+ T cells freshly isolated from 
c-Rel–deficient  mice  produced  significantly  less  IL-17A 
mRNA and protein upon activation with anti-CD3 and anti-
CD28 (Fig. 1, A and B). This was associated with reduced 
levels of both ROR and RORT mRNAs as compared 
with WT cells (Fig. S1 A). Consistent with this result, we 
found that c-Rel deficiency caused a 46% reduction in the 
frequency of Th17 cells in the lung (1.1 ± 0.1% in WT as 
compared with 0.6 ± 0.05% in c-Rel KO mice), and 44% 
reduction in the Peyer’s patches (1.6 ± 0.1% in WT as com-
pared with 0.9 ± 0.07% in c-Rel KO mice; P < 0.03 for both 
organs). Importantly, when purified naive CD4+ T cells 
were cultured under Th17 cell–inducing conditions, IL-17A   
expression was significantly reduced in the c-Rel–deficient 
group, leading to 50% reduction in Th17 cell frequencies 
(Fig. 1, C and D); this reduction was more dramatic (up to 
80%) if anti–IL-2 was added to the culture twice and phorbol 
myristate acetate (PMA) and ionomycin were not used to 
stimulate the cells (Fig. S1 B). c-Rel deficiency not only re-
duced the Th17 cell frequency, but also decreased the levels 
of IL-17 in differentiated Th17 cells by 50% (Fig. S1 C). 
Because IL-2 represses Th17 differentiation through Stat5 
(Laurence et al., 2007), the percentage of Th17 cells was 
higher in the presence of anti–IL-2.
In addition to IL-6, IL-1 and IL-23 can also drive Th17 
cell differentiation. The effect of c-Rel deficiency on IL-1– 
and IL-23–induced Th17 cell differentiation was even more 
Figure 1.  T cells deficient in c-Rel or p65 are significantly com-
promised in their IL-17 gene expression and Th17 differentiation. 
(A and B) CD4+ T cells were isolated from 6-wk-old WT and Rel/ mice  
(n = 5), and stimulated with anti-CD3 and anti-CD28 in the presence of 
anti–IL-2 and anti–IFN- for 6 h (A), or 48 h (B). Total RNA was extracted, 
and IL-17 mRNA levels were determined by real-time RT-PCR (A). The 
cytokine concentrations in the culture supernatants were determined by 
ELISA (B). (C and D) Purified CD4+ naive splenic T cells from WT and Rel/ 
mice (n = 5) were cultured under Th17 cell–inducing conditions, as de-
scribed in Materials and methods, with or without anti–IL-2 for 3 d. Cells 
were then restimulated with PMA and ionomycin in the presence of Golgi-
Stop for 4 h, stained intracellularly with antibodies to IL-17A, and ana-
lyzed by flow cytometry. In C, IL-17A expression level of cells cultured 
with anti–IL-2 was plotted against CD4. In D, the percentages of IL-17A-
expressing cells (as shown in C) from each group were compared. Error 
bars indicate the SDs of the means. (E) Purified CD4+ naive splenic T cells 
from WT and Rel/ mice (n = 3) were incubated with 5 µM of CFSE for 
10 min. After washing, cells were cultured under the Th17 cell–inducing 
condition, as described in Materials and methods. 3 d later, cells were 
restimulated with PMA and ionomycin in the presence of GolgiStop for 4 h,  
stained intracellularly with antibodies to IL-17A, and analyzed by flow 
cytometry. Each numerical figure in the graph represents the percentage 
of cells with the same number of divisions in the gated area. (F) p65/ 
and p65+/+ chimeric mice were generated by adoptively transferring 
p65/ and p65+/+ fetal liver cells, respectively, into irradiated B6 recipi-
ents as previously described (Ouaaz et al., 2002). 6 wk later, mice were 
sacrificed and CD4+ naive splenic T cells isolated. Cells were cultured under 
Th17 cell–inducing medium for 3 d, as described in Materials and 
methods. They were then restimulated and tested as described in C. The 
number in each panel represents the percentage of gated IL-17A–producing 
cells in total CD4+ cells. Results are representative of three independent 
experiments. *, P < 0.01.
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These results indicate that c-Rel and p65 play critical roles in 
Th17 responses, and deficiency in one may only be partially 
compensated by the other.
ROR and RORT expression is markedly reduced  
in c-Rel–deficient T cells, and their reconstitution  
rescues the Th17 defect
c-Rel–deficient T cells have a defect in their Th1 but not 
Th2 responses (Hilliard et al., 2002). To establish the degree 
to which Th17 response was affected in these cells, we exam-
ined the expression of seven Th17-related genes at different 
stages of Th17 differentiation. We found that c-Rel defi-
ciency  significantly  reduced  the  expression  of  RORT, 
ROR, ROR4, IL-6, IL-17A, and IL-21, but not Stat3 
mRNAs (Fig. 2 A and Fig. S4 A). As expected, RORT and 
ROR protein levels were also markedly reduced in c-Rel–
deficient T cells (Fig. S4 B). Because RORT plays a key 
role  in  Th17  differentiation,  we  next  examined  whether 
RORT or ROR reconstitution in c-Rel–deficient cells 
could rescue the Th17 defect. After infection of T cells with 
a retrovirus that carried either RORT or ROR cDNA, 
significant increases in the number of Th17 cells were ob-
served in both WT and c-Rel–deficient groups. This was 
true for T cells cultured under either Th0 (Fig. 2 B) or Th17 
(Fig. S4 C) cell–inducing conditions. RORT and ROR 
were both effective in driving IL-17 expression, and coex-
pressing them together did not appear to generate any syner-
gistic effect (Fig. S4 C; unpublished data). The difference in 
the frequency of IL-17A producers between WT and c-Rel–
deficient cells (Fig. 2 B) was most likely caused by the in-
creased  IL-2  production  in  WT  cultures  (Hilliard  et  al., 
2002). Importantly, similar to the reported effect of RORT, 
ROR also drove the expression of other Th17 signature 
molecules such as IL-17F, CCR6, IL-22, and IL-23R (Fig. 2, 
C and D). Because T cell proliferation may affect Th17 cell 
development, we also examined whether enforced expres-
sion of ROR or RORT had any effect on the prolifera-
tion of Rel/ cells. Our data showed that enforced expression 
of neither ROR nor RORT rescued the proliferation de-
fect of Rel/ T cells (Fig. S5, A and B).
Similar to RORT, ROR is preferentially expressed in Th17 
cells and is effective in driving Th17 differentiation
Although it is well recognized that RORT plays a key role 
in specifying Th17 differentiation, whether ROR plays a 
similar role is unknown. During in vitro Th cell differentia-
tion, Th17-like cells expressed the highest levels of ROR, 
in addition to RORT (Fig. 3, A and B), although RORT 
was clearly more abundant than ROR (Fig. 3 C). T reg 
cell–like cells also expressed ROR and RORT during the 
differentiation stage, although their levels were much lower. 
Low levels of ROR, but not RORT, were also detected 
in Th1- and Th2-like cells at this stage (Fig. 3, A and B). 
ROR is known to be expressed in nonhematopoietic cells, 
with the highest expression levels detected in the kidney and 
liver. We therefore compared ROR mRNA copy numbers 
dramatic,  reducing  the  Th17  cell  frequency  by  80%   
(Fig. S1 D). It has been reported that IL-17+IFN-+ cells 
can be induced by IL-6, IL-23, and IL-1. Because c-Rel also 
regulates  IFN-  expression,  we  next  examined  whether   
c-Rel deficiency affected the generation of IL-17+IFN-+ 
cells. We found that the frequency of IL-17 and IFN- double- 
positive  cells  was  markedly  reduced  in  c-Rel–deficient   
cultures (Fig. S1 E). Rel/ T cells may have reduced pro-
liferation  (Hilliard  et  al.,  2002).  To  determine  whether   
c-Rel regulates Th17 cell differentiation independent of its 
effect on cell proliferation, we repeated the Th17 differentia-
tion  experiment  using  naive  CD4+  T  cells  labeled  with 
CFSE, which allows direct tracking of cell divisions by flow 
cytometry. As expected, Rel/ T cells have reduced prolif-
eration (Fig. S2 A). Th17 differentiation peaked after the 
fourth cell division in both WT and Rel/ groups (Fig. 1 E). 
Importantly, the percentage of Th17 cells generated was sub-
stantially reduced in the Rel/ group even when cells that 
had undergone the same number of cell divisions were com-
pared. Although a small population of cells that had under-
gone no division or less than two divisions also produced 
low levels of IL-17 (as indicated by a weak IL-17 signal; 
Fig. 1 E), they were likely uncommitted Th0-type cells, not 
Th17 cells, and were less affected by the c-Rel deficiency. 
T cell death as determined by flow cytometry was not sig-
nificantly  affected  by  the  c-Rel  deficiency.  Rel/  mice 
used in this study were >7 wk old, and did not have signifi-
cantly reduced splenic CD4+ T cells as compared with WT 
mice. There were no significant differences in the expres-
sion of CD44 and CCR6 between WT and Rel/ T cells 
(Fig. S2 B). Upon activation, a low percentage of Rel/  
T cells produced IFN-, but few WT or Rel/ T cells 
produced IL-22 (Fig. S2 C).
Because significant numbers of Th17 cells were generated 
in the absence of c-Rel, we asked whether other members   
of the Rel/NF-B family played a role in Th17 differentia-
tion. We found that p65/ CD4+ T cells had a greater defect 
in Th17 differentiation than Rel/ T cells (Fig. 1 F). Up to 
70% reduction in Th17 cell frequencies was observed in the 
p65/ group as compared with the WT group. Using CFSE-
labeled p65/ cells, we found that p65 deficiency signifi-
cantly blocked Th17 differentiation, even when cells that   
had undergone same numbers of divisions were compared 
(Fig. S3 A). Specifically, the percentages of Th17 cells were 
reduced from 32.2% in WT to 12.5% in p65 cultures after 
four divisions, and from 19.9% in WT to 11.5% in p65 cul-
tures after three divisions (P < 0.01). To ensure that the culture 
condition we used was effective in driving Th17 differentia-
tion, unlabeled cells were also cultured in a nondifferentia-
tion medium. Few IL-17–producing cells were generated in 
the latter medium (Fig. S3 B). Because p65 deficiency causes 
embryonic lethality, fetal liver transfer was performed to gen-
erate the p65-deficient cells, as previously described (Ouaaz 
et al., 2002). In contrast to c-Rel and p65, p50 and RelB 
were dispensable because T cells deficient in them exhibited 
no defects in Th17 cell differentiation (unpublished data). 2324 Rel in Th17 immunity | Ruan et al.
in Th17 cells to those in the kidney and liver. We found that 
the ROR mRNA in Th17 cells was approximately one-
half and one-fourth of those in the liver and kidney, respec-
tively (Fig. 3 D). These results indicate that ROR, in addition 
to RORT, may be involved in specifying Th17 differentia-
tion. Indeed, ROR was at least as effective as RORT in 
activating the Il17a promoter (Fig. 3, E and F). And enforced 
expression of ROR through retroviral gene transfer induced 
Th17 differentiation even under Th0-, Th2-, and T reg cell–
polarizing conditions (Fig. 3 G). Enforced expression of ROR 
also decreased IL-4 levels under Th2-polarizing condition, but 
not IFN- under Th1-polarizing condition or Foxp3 under 
T reg cell–polarizing condition (Fig. S6 A). Because it has 
been reported that RORT activates the Il17a gene by bind-
ing to its conserved noncoding sequence (CNS) 2 region (Yang 
et al., 2008), we performed chromatin immunoprecipitation 
(ChIP) analysis of this region for ROR binding. Because 
the currently available anti-ROR antibodies do not distin-
guish ROR from RORT, we infected CD4+ T cells with 
a retrovirus that encodes Flag-tagged ROR, or a combina-
tion of equal amounts of ROR-Flag and RORT retro-
viruses. ROR-Flag binding to the Il17a gene was detected 
in both conditions, although RORT retrovirus infection 
reduced the ROR-Flag binding suggesting competition be-
tween ROR and RORT (Fig. S6 B). Collectively, these 
data indicate that in addition to RORT, ROR may also 
be involved in driving Th17 differentiation.
ROR and RORT expression is controlled by two different 
promoters in Th17 cells
The Rorg gene encodes both ROR and RORT that are 
different in their N-terminal sequences. Whether this is a re-
sult of differential usage of different promoters or differential 
splicing of the same pre-mRNA in Th17 cells is not clear.   
To address this issue, we undertook three complementary   
approaches. First, we performed 5-RACE (rapid amplifica-
tion of cDNA ends) using a cap-dependent RACE kit to 
identify the transcription start sites (TSS) of Rorg mRNA   
in newly differentiated Th17 cells. This led to the discovery 
of two different types of ROR mRNAs in Th17 cells, with 
unique 5 capped ends corresponding to two predicted TSS 
of the Rorg gene (Fig. 4, A and B; Fig. S7; and Fig. S8). The 
Rorgt TSS we identified in Th17 cells is identical to that re-
ported for thymocytes (Xi et al., 2006), whereas the Rorg TSS 
we identified is the same as the one reported for hepatocytes 
(Medvedev et al., 1997).
Second, we asked whether the RNA polymerase II (PolII) 
was able to bind to the two putative Rorg promoters during 
Th17 differentiation by ChIP. We found that although they 
followed different kinetics, both Rorg and Rorgt promoters 
associated with PolII during Th17 differentiation, especially 
at a later stage (Fig. 4 C). As expected, the binding was sig-
nificantly reduced in Rel/ cells (Fig. 4 D). Each Rorg pro-
moter contains several CNS regions (Fig. S7 and Fig. S8).   
A TATA box and putative binding sites for several transcription 
factors including SP1, NFAT, AP-1, and GATA3, as well as 
Figure 2.  ROR and RORT expression is significantly reduced in 
c-Rel–deficient T cells, and ROR reconstitution rescues the Th17 
defect. (A) Purified naive CD4+ splenic T cells from 6-wk-old WT (n = 5) 
and Rel/ (n = 5) mice were cultured under Th17 differentiation condi-
tion as described in Materials and methods. Cells were collected at differ-
ent time points as indicated, and total RNA was extracted. The mRNA 
levels of the indicated genes were determined by real-time RT-PCR and 
normalized to GAPDH. Error bars indicate the SDs of the means, which  
are visible only if they are bigger than the diameters of the symbols.  
(B) Purified splenic CD4+ T cells from WT (n = 5) and Rel/ mice (n = 5) 
were cultured under Th0-inducing conditions in the presence of anti–IL-4 
and anti–IFN- for 24 h. Cells were then infected with recombinant retro-
viruses that carry EGFP (Vector as a control), ROR-EGFP (ROR), or 
RORt-EGFP (RORt) cDNA as described in Materials and methods. 4 d 
later, cells were restimulated with PMA and ionomycin and stained intra-
cellularly with anti–IL-17A, and analyzed by flow cytometry. Data shown 
are for gated EGFP+ cells. Results are representative of two independent 
experiments. (C and D) Splenic CD4+ T cells were isolated from 6-wk-old 
WT (C) and Rel/ (D) mice (n = 3), and infected with recombinant retro-
viruses that carry EGFP (vector control), ROR-EGFP, or RORT-EGFP 
cDNA, as described in B. 4 d later, EGFP+ cells were sorted, total RNA was 
extracted, and mRNA levels of the indicated genes were determined by 
real-time RT-PCR. Data shown are fold increases over vector-treated 
groups, and are means and SD of triplicate cultures. Results are represen-
tative of two independent experiments.JEM Vol. 208, No. 11 
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Rel/NF-B, are present within, or close to, the CNS-1 re-
gion. Collectively, these results indicate that differential pro-
moter usage is likely responsible for the production of the 
two isoforms of the Rorg proteins.
Third,  we  tested  whether  the  putative  Rorg  promoter   
(nt 771 to +98; Fig. S7) and the Rorgt promoter (nt 400 
to +151; Fig. S8) had any detectable promoter activity in   
the Th17-like EL-4 cells. We found that although the Rorgt 
promoter was less sensitive than the Rorg promoter to stimu-
lation, both promoter constructs could drive luciferase ex-
pression (Fig. 5 A). In fact, even in the absence of stimulation, 
the Rorgt promoter had a detectable basal activity. This is remi-
niscent of the study by Xi et al. that Rorgt promoter is constitu-
tively active in a thymocyte cell line (Xi et al., 2006).
Rel activates both Rorg and Rorgt promoters, but not those 
of Rora4 and Il17a
Although c-Rel–deficient T cells have a defect in IL-17A 
and ROR expression, c-Rel does not appear to regulate 
their promoter activities. Thus, the Il17a promoter con-
struct containing its CNS2 enhancer was readily activated   
by ROR and RORT, but not by any members of the   
NF-B family (Fig. 5 B). Similarly, c-Rel did not activate the 
promoter construct of Rora4 (our unpublished data). These 
results indicate that the c-Rel effect on Th17 cells may be 
gene-specific.
To test the theory that Rel proteins control Rorg gene 
expression, we examined whether they activate the Rorg  
promoters in luciferase-based promoter reporter assays. We 
found that c-Rel and p65, but not p50 or RelB, significantly 
activated the Rorg promoters upon coexpression (Fig. 6 A; 
unpublished data). p50 and RelB failed to activate the Rorg 
promoters even when co-transfected together (unpublished 
data). This indicates that the Rel/NF-B family of transcrip-
tion factors may regulate Rorg gene expression in a member-
specific manner.
Rel binds to both Rorg and Rorgt promoters and controls 
their activities through specific Rel sites
To identify the c-Rel–responsive region in the murine Rorg 
promoter, we performed deletional analysis of the promoter. 
We found that nucleotides 471 to 167 were required for 
the c-Rel activity (Fig. 6 B). A close examination of the nu-
cleotide sequence in this region using the Transcription Ele-
ment Search System (TESS) software revealed two putative 
Rel (or NF-B) binding sites (Rel1, 201 to 193; Rel2, 
288 to 280), and a putative NFAT-binding site (96 to 
90; Fig. S7). To determine whether these sites were required 
Figure 3.  RORT and ROR activate the Il17 promoter and drive 
Th17 differentiation. (A and B) Purified CD4+ T cells were cultured under 
conditions that induce Th0, Th1, Th2, Th17, and T reg cells as described in 
Materials and methods. 3 d later, cells were harvested and restimulated 
with PMA and ionomycin for an additional 3 h. The RORT (A) and ROR 
(B) mRNA levels were determined by real-time RT-PCR, and are presented 
as fold increases over that of the Th0 cells. Data shown are representative 
of two independent experiments. (C and D) Total RNA was extracted from 
naive CD4+ T cells (Naive), Th17 cells, thymocytes, peritoneal macro-
phages, kidney, and liver of B6 mice as indicated. The mRNA copy num-
bers of ROR and RORT were determined by real-time RT-PCR using the 
respective cDNAs as standards. (E and F) EL4 T cells were transiently 
transfected with luciferase constructs of the murine Il17a promoter (Il17 
Pro) or Il17a promoter linked to its CNS2 (Il17 Pro + CNS2), together with 
an expression vector for full-length RORT (C) or ROR (D), or the empty 
vector as indicated. After 24 h, cells were treated with PMA and ionomy-
cin for 4 h, and the luciferase activities measured. The promoter activity is 
presented as fold increase over cells transfected with the empty vector.  
To normalize the transfection efficiency across samples, the Renilla lucifer-
ase expression vector pRLTK was used as an internal control. Data are 
representative of two independent experiments. *, P < 0.01. (G) Purified 
CD4+ T cells were cultured under conditions that induce Th0, Th1, Th2, 
Th17, and T reg cells for 24 h, and then infected with retroviruses that 
encode EGFP (Vector) or ROR and EGFP (ROR) as described in Materials 
and methods. 4 d later, cells were restimulated with PMA and ionomycin 
in the presence of GolgiStop for 4 h, stained intracellularly with antibodies  
to IL-17A, and analyzed by flow cytometry. Data shown are for gated 
EGFP+ cells. The experiment was repeated twice with similar results.
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c-Rel and p65 response (Fig. 6 C; unpublished data). Simi-
larly, the Rorgt promoter contains a putative Rel site (Rel2, 
268  to  260)  and  a  putative  Rel-NFAT–binding  site 
(Rel1-NFAT, 166 to 156; Fig. S8). To identify the Rel-
responsive site, we tested, in a luciferase reporter assay, the 
WT Rorgt promoter construct (400 to +151) and its mu-
tants (Fig. 7 A). We found that both Rel site mutations sig-
nificantly reduced the Rorgt promoter activity, indicating that 
Rel regulates the Rorgt promoter through these sites.
To directly test c-Rel binding to the identified Rel nu-
cleotides of the Rorg and Rorgt promoter, we performed nu-
cleotide pull-down analyses using both wild-type and mutant 
Rel nucleotides. We found that c-Rel readily bound to the 
for c-Rel and p65 actions, we mutated them either individu-
ally or in combination. We found that both Rel1 and Rel2 
sites, but not the putative NFAT site, were required for the 
Figure 4.  Identification of two Rorg promoters that control ROR 
and RORT expression in Th17 cells. (A) The translation start sites for 
ROR and RORT promoters are indicated by triangles and their TSS 
marked with arrows. Only 3 of the 11 Rorg exons are shown. (B) Purified 
CD4+ T cells from 6-wk-old WT mice (n = 3) were cultured under Th17 
differentiation condition for 17 h, as described in Materials and methods. 
Total RNA was extracted and treated with RNase-free DNase I. 5-RACE 
was performed and the PCR products of the 5 ends of ROR and RORt 
mRNA were visualized by agarose gel electrophoresis (which were then 
cloned and sequenced). (C) Purified CD4+ T cells from 6-wk-old WT mice 
(n = 3) were cultured under Th17 differentiation conditions, as described 
in Materials and methods. At the indicated times, cells were fixed, and 
ChIP was performed using antibodies to RNA polymerase II (PolII) or con-
trol IgG. (D) Purified naive CD4+ T cells from WT (n = 3) and Rel/ mice 
(n = 3) were cultured under Th17 differentiation conditions, as described 
in Materials and methods. At the indicated times, cells were fixed, and 
ChIP was performed using antibodies to PolII. Error bars indicate the SEM. 
Data are representative of two independent experiments (*, P < 0.05).
Figure 5.  Rorg and Il17 promoters. (A) EL4 T cells were transfected with 
empty pGL3 vector, Rorg, or Rorgt promoter constructs with or without a 
c-Rel expression plasmid as indicated. After 24 h, cells were treated with or 
without 50 ng/ml PMA and 1 µM ionomycin (I) for 5 h and the luciferase 
activities of whole-cell lysates were analyzed as described in Materials and 
methods using a dual-luciferase reporter assay system. (B) EL4 cells were 
transiently transfected with murine Il17a core promoter or Il17a core  
promoter-CNS2 luciferase construct together with an expression vector for 
full-length RORT, ROR, p50, p52, c-Rel, p65, p100, or RelB, or the empty 
vector as indicated. After 24 h, cells were treated with PMA and ionomycin 
for 4 h, and the luciferase activities measured. The promoter activity is  
presented as fold increase over cells transfected with empty vector.  
To normalize the transfection efficiency across samples, the Renilla luciferase 
expression vector pRLTK was included as an internal control. Data are repre-
sentative of two independent experiments. *, P < 0.01.JEM Vol. 208, No. 11 
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nucleotides of all four Rel sites, but not their mutants (Fig. 6 D 
and Fig. 7 B).
To establish whether Rel binds to the Rorg and Rorgt 
promoter in Th17 cells, we performed ChIP analysis. The 
Rorg and Rorgt DNA–protein complexes were precipitated 
using specific antibodies to c-Rel and p65 at different time 
points of Th17 differentiation. The nature of the precipitated 
DNA was then defined by PCR using primers specific for 
Rorg and Rorgt promoter. We found that in resting naive   
T cells, the Rorg and Rorgt promoter was devoid of c-Rel and 
p65. 17 h after Th17 differentiation, c-Rel and p65 were read-
ily detected on both the Rorg and Rorgt promoter (Fig. 6 E 
and Fig. 7 C). In addition to Rorg and Rorgt, c-Rel also bound 
to Il2, but not Il17a, during Th17 differentiation (Fig. 7 D). 
Re-ChIP analysis showed that c-Rel and p65 colocalized in 
the same complex (Fig. 8, A and B). p65 was also detected on 
the Rorg and Rorgt promoters in Rel/ T cells during Th17 
differentiation (Fig. 8, C and D). This result may explain why 
significant  numbers  of  Th17  cells  were  generated  in  the   
absence of c-Rel,
These results indicate that c-Rel is required for activating 
the Rorg and Rorgt promoter during Th17 differentiation. To 
directly test this possibility, we measured the Rorgt promoter 
activity in differentiating Th17 cells. We found that c-Rel 
deficiency  significantly  diminished,  whereas  c-Rel  over-
expression enhanced, the Rorgt promoter activity (Fig. 8, E and F). 
Additionally, we found that mutating the Rel binding sites of 
the Rorgt promoter significantly reduced its activity in pri-
mary Th17 cells (Fig. 8 G). These results establish that c-Rel 
not only can, but also does, activate the Rorgt promoter in 
Th17 cells.
c-Rel–deficient mice have diminished autoimmune  
Th17 responses
Th17 cells play crucial roles in the pathogenesis of auto-
immune diseases. Because c-Rel–deficient T cells have a defect 
in Th17 differentiation, we asked whether Th17 responses to 
self-antigens were affected in c-Rel–deficient mice. As we 
reported, c-Rel–deficient mice were resistant to experimen-
tal autoimmune encephalomyelitis (EAE), an animal model 
for multiple sclerosis (Hilliard et al., 2002). To determine 
whether anti-self MOG (myelin oligodendrocyte glycopro-
tein) Th17 response was affected by the c-Rel deficiency, we 
immunized  WT  and  c-Rel–deficient  mice  with  a  MOG 
Figure 6.  c-Rel binds to and activates the Rorg promoter through 
two specific Rel sites. (A) EL4 cells were transiently transfected with 
murine Rorg promoter luciferase construct together with an expression 
vector for full-length c-Rel, p65, p50, or RelB, or the empty vector as 
indicated. After 24 h, cells were treated with PMA and ionomycin for 5 h, 
and the luciferase activities measured. The promoter activity is presented 
as fold increase over cells transfected with empty vector. To normalize the 
transfection efficiency across samples, the Renilla luciferase expression 
vector pRLTK was included as an internal control. (B) Deletion mutants of 
the Rorg promoter were analyzed in the luciferase reporter assay with or 
without c-Rel co-transfection. Putative binding sites for c-Rel (Rel1 and 
Rel2) and NFAT are indicated. (C) WT and Rel or NFAT site-mutated Rorg 
promoter constructs were analyzed in the luciferase reporter assay with 
or without c-Rel co-transfection. The Rel1 site was mutated to 
TGGGACTCG (201 to 193), the Rel2 site to CTGAAGTGC (288 to 
280), and the NFAT site to TTGTCAC (96 to 90). The “X” indicates the 
mutated site. (D) Nuclear extracts were prepared from EL4 cells after 
stimulation for 6 h with PMA and ionomycin. Biotinylated Rorg Rel oligo-
nucleotides or their mutants were absorbed by streptavidin-agarose 
beads, and then added to the nuclear extracts. The amount of c-Rel pro-
teins in the precipitates were assessed by immunoblotting with anti–c-Rel. 
(E) Purified CD4+ T cells from 6-wk-old WT mice (n = 3) were cultured 
under Th17 differentiation conditions, as described in Materials and 
methods. After 17 h, cells were fixed, and ChIP was performed using anti–
c-Rel or control IgG. *, P < 0.01. Data are representative of three (A–D) 
and two (E) independent experiments, respectively.
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peptide and examined the splenic T cell response to the self-
peptide 2 wk later. We found that the anti-MOG Th17 re-
sponse  (as  measured  by  IL-17  and  IL-6  production)  was 
significantly reduced in c-Rel–deficient mice as compared 
with their WT littermates (Fig. 9 A). To determine whether 
the in vivo effect of c-Rel on Th17 development was T cell 
intrinsic, we transferred WT and Rel/ T cells into Rag1/ 
mice. Mice were then immunized with MOG peptide, and 
the splenic T cell responses to MOG were tested 2 wk later. 
The results showed that Rel/ T cells produced significantly 
less IL-17 as compared with WT T cells (Fig. 9 B).
To determine if c-Rel deficiency affects other models of 
autoimmunity, we crossed our c-Rel–deficient B6 mice with 
a NOD mouse line that carried a transgenic diabetogenic 
Figure 7.  c-Rel binds to and activates the Rorgt promoter through 
two Rel sites. (A) WT and Rel site-mutated Rorgt promoter constructs 
and the empty vector were analyzed in a luciferase reporter assay with  
c-Rel co-transfection. The “X” indicates the mutated (Mu) Rel site. Data 
are representative of three independent experiments. (B) Nuclear extracts 
were prepared from EL4 cells after stimulation for 6 h with PMA and iono-
mycin. Biotinylated Rorgt Rel oligonucleotides or their mutants were 
absorbed by streptavidin-agarose beads, and then added to the nuclear 
extracts. The amount of c-Rel proteins in the precipitates were assessed 
by immunoblotting with anti–c-Rel. (C) Purified CD4+ T cells from 6-wk-
old WT mice (n = 3) were cultured under Th17 differentiation condition as 
described in Materials and methods. After 17 h, cells were fixed, and ChIP 
was performed using anti–c-Rel or control IgG. Data are representative of 
two independent experiments. (D) Purified CD4+ T cells from 6-wk-old WT 
mice (n = 3) were cultured under Th17 differentiation conditions, as de-
scribed in Materials and methods. After 17 h, cells were fixed, and ChIP 
was performed using anti–c-Rel. Data are representative of two indepen-
dent experiments.
Figure 8.  Rel controls Rorg promoter activities in primary Th17 
cells. (A and B) Purified naive CD4+ T cells from WT (n = 3) mice were 
cultured under Th17 differentiation conditions, as described in Materi-
als and methods. At indicated times, cells were fixed, and ChIP was 
performed using anti-p65 antibody. Re-ChIP was performed with 
anti–c-Rel using DNA precipitated by anti-p65. (C and D) Purified  
naive CD4+ T cells from 6-wk-old Rel/ mice (n = 3) were cultured 
under Th17 differentiation conditions, as described in Materials and 
methods. After 17 h, cells were fixed, and ChIP was performed using 
anti-p65 antibody. (E–G) Naive CD4+ T cells from WT (E–G; n = 3) and 
Rel/ mice (E; n = 3) were transiently transfected with WT (E–G) and 
Rel sites mutated (E) murine Rorgt promoter luciferase constructs 
using Amaxa Nucleofector reagent. An expression vector for full-
length c-Rel was also used to co-transfect cells in E. Cells were cul-
tured under Th17 differentiation condition for 24 h, and the luciferase 
activities measured. To normalize the transfection efficiency across 
samples, the Renilla luciferase expression vector pRLTK was included 
as an internal control. Error bars indicate the SEM. Data are represen-
tative of two independent experiments.JEM Vol. 208, No. 11 
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the Foxp3 gene only when all the essential factors are pres-
ent (Ruan et al., 2009). This concept explains how nonlineage-
specific factors such as c-Rel control gene expression in a 
lineage-specific manner. Data presented in this work indicate 
that c-Rel and p65 may regulate Rorg gene expression in a 
similar manner, i.e., by forming an enhanceosome that in turn 
controls the on and off states of the Rorg gene. It is to be em-
phasized that the transcription factors (c-Rel and p65) we 
identified are the only known ones that bind to and activate 
Rorg promoters. Stat3 was recently shown to bind to the first 
intron of the Rorg gene, but not the promoter (Durant et al., 
2010). The nature of other Rorg promoter-binding transcrip-
tion factors remains to be established.
Unlike RORT, which is primarily expressed in devel-
oping thymocytes and Th17 cells, ROR is expressed in a 
variety of cell types (He et al., 1998; Villey et al., 1999). 
However, naive T cells and Th0 cells do not express ROR. 
Upon Th differentiation, ROR is most significantly up-
regulated in Th17 cells and is able to specify the Th17 phe-
notype. Therefore, at least in T cells, ROR shares similar 
expression patterns and functions with RORT. Because we 
found evidence for the presence of two active Rorg promoters 
and two types of 5-capped ROR mRNAs in Th17 cells, 
we propose that RORT and ROR are generated by   
differential  usage  of  promoters.  It  has  been  recognized   
that more than one ROR member is involved in Th17 dif-
ferentiation. Thus, Th17 cells were detected in Rorg knock-
out cultures that lack both RORT and ROR (Ivanov   
et  al.,  2006),  and  Th17  responses  could  be  completely 
blocked only in mice that lacked all three ROR members, 
i.e.,  RORT,  ROR,  and  ROR  (Yang  et  al.,  2008). 
Therefore,  no  single  ROR  protein  deficiency  may  com-
pletely block Th17 differentiation. One of our novel findings 
is that ROR, which is not expressed in naive T cells, is se-
lectively induced in Th17 cells by c-Rel, and controls Il17 
gene expression. Although non–T cells can express ROR, 
they may not express IL-17. This may be because 
of the fact that other T cell–associated factors, in 
TCR called BDC2.5 (Gonzalez et al., 1997). All WT proge-
nies  developed  autoimmune  diabetes  upon  challenging 
with cyclophosphamide (CY) even though they were of a 
mixed MHC background. Remarkably, none of the c-Rel– 
deficient  mice  developed  diabetes  as  measured  by  blood 
glucose levels (Fig. S9 A). Consistent with these results, sple-
nocytes  from  c-Rel–deficient  mice  produced  significantly 
lower levels of IL-17A, IL-6, IL-2, and IFN- than WT cells 
upon stimulation with anti-CD3, with or without anti-CD28 
(Fig. S9 B). Flow cytometric analysis revealed that in CD4+ 
T cells, both Th1 and Th17 cytokines were reduced as a re-
sult of the c-Rel deficiency (our unpublished data). Collec-
tively, these results indicate that autoreactive Th17 responses 
are markedly diminished in c-Rel–deficient mice.
DISCUSSION
How Th17 cells are generated remains enigmatic. Results re-
ported here enable us to propose the following model (Fig. 5): 
APCs engage naive CD4+ T cells by TCR and CD28, in the 
presence of IL-1, IL-6, IL-23, and TGF-; ligation of TCR, 
CD28, IL-1, and possibly IL-23 receptors leads to the activa-
tion of IKK, which phosphorylates IB (inhibitor of B), 
releasing c-Rel and p65. We propose that the freed c-Rel-p65 
dimer migrates into the nucleus, binds to the Rorg and Rorgt 
promoters, and initiates Th17 differentiation, with the help 
of other factors such as NFAT and Stat. Thus, although the 
Rorg gene specifies Th17 lineage differentiation (Ivanov et al., 
2006), its own expression may not be controlled by lineage-
specific factors. Similar principles also apply to other lineage-
specifying genes, including Foxp3, which is controlled by 
c-Rel. In the latter case, c-Rel forms a multifactorial complex 
called the enhanceosome, together with other nonlineage- 
specific factors, to control the on and off states of the Foxp3 
gene. Although each factor in the enhanceosome is not 
unique, the complex as a whole is (Ruan et al., 2009). The 
enhanceosome operates as a “coincidence detector,” turning on 
Figure 9.  MOG-induced Th17 cytokine production by 
WT and Rel/ splenocytes. (A) WT (Rel+/+) and c-Rel–
deficient (Rel/) C57BL/6 mice (n = 3) were immunized s.c. 
with 200 µg MOG38-50 peptide in 0.1 ml PBS emulsified in 
an equal volume of complete Freund’s adjuvant containing 
400 µg Mycobacterium tuberculosis H37RA. 14 d later, mice 
were sacrificed, and their splenocytes (5 × 106/ml) were cul-
tured with or without MOG38-50 peptide as indicated. Cul-
ture supernatants were collected 40 h later and tested for 
cytokines by ELISA (Hilliard et al., 2002). (B) Purified T cells 
from WT (Rel+/+) and c-Rel–deficient (Rel/) C57BL/6 mice 
(n = 3) were transferred into Rag1/ C57BL/6 mice via tail 
vein. Mice were treated and the splenic T cell responses to 
MOG examined as in A. Graphs show means ± SD of tripli-
cate cultures. The differences between the two groups for all 
cultures with MOG are statistically significant (P < 0.01). 
Data are representative of two experiments.2330 Rel in Th17 immunity | Ruan et al.
transcription factors. However, because Rorg expression is 
induced during Th17 differentiation, Bunting et al. (2007) 
did not detect it in their cells, which were not of the Th17 
type. Therefore, in addition to Rorg, other c-Rel target genes 
could  also  regulate  Th17  responses  in  a  cell  autonomous 
manner. For example, both Il2 and Foxp3 are c-Rel target 
genes that are known to promote T reg cell differentiation 
and inhibit Th17 differentiation (Isomura et al., 2009; Long 
et al., 2009; Ruan et al., 2009; Zheng et al., 2010). Because 
c-Rel–deficient T cells produce less IL-2 than WT T cells, 
the effect of c-Rel deficiency on Th17 differentiation could 
be masked if anti–IL-2 was not included in the Th17 differ-
entiation medium (Liou et al., 1999; Visekruna et al., 2010).
In summary, we have discovered that c-Rel and p65 play 
critical roles in Th17 immune responses. This finding may 
not only help advance our understanding of the Th17 differ-
entiation  program,  but  also  aid  in  developing  new  drugs   
targeting Rel and ROR for the treatment of inflamma-
tory diseases.
MATERIALS AND METHODS
Mice. 7–8-wk-old C57BL/6 (B6) mice that carry a Rel gene null mutation 
were generated as previously described, and were backcrossed to B6 mice for   
12 generations before used in this study (Liou et al., 1999; Hilliard et al., 2002). 
p65-deficient fetal liver chimeric B6 mice were generated as previously de-
scribed (Ouaaz et al., 2002). B6.NOD F1 mice were generated by crossing 
Rel/ B6 and NOD BDC2.5 TCR transgenic mice (Gonzalez et al., 1997). 
The F1 mice were then crossed to generate Rel/ and Rel+/+ B6.NOD 
BDC2.5 TCR transgenic mice. All B6.NOD F2 mice used in this study 
were H-2 of b and g7 and express the BDC2.5 transgenic TCR as deter-
mined by flow cytometry. All mice were housed in the University of Penn-
sylvania animal care facilities under pathogen-free conditions, and all procedures 
were preapproved by the Institutional Animal Care and Use Committee.
Induction and clinical evaluation of diabetes. 7–8-wk-old B6.NOD 
BDC2.5 TCR transgenic mice were injected i.p. with 200 mg/kg CY. Mice 
were tested every other day for blood glucose levels, and were considered 
diabetic if the glucose levels equaled or exceeded 250 mg/dl on two consec-
utive tests.
Recombinant retroviruses. The recombinant RORT retrovirus was a 
gift from D.R. Littman (New York University, New York, NY; Ivanov   
et al., 2006). A recombinant ROR retrovirus was generated by inserting 
the murine ROR cDNA with or without a Flag tag into the XhoI and 
EcoRI site of the MigR1 vector, and by transfecting 293T cells with the re-
combinant plasmid (Pear et al., 1998; Pui et al., 1999; Sun et al., 2008). In 
the recombinant viral genome, the ROR or RORT cDNA lies directly 5 
of an internal ribosome entry site, which is followed by a cDNA encoding 
enhanced GFP (EGFP).
T cell isolation and differentiation. Naive CD4+CD25CD44lowCD62L+ 
splenic T cells were isolated by FACS after staining the cells with the spe-
cific antibodies. Total CD4+ T cells were isolated using an autoMACS cell 
sorter after staining splenocytes with anti-CD4. Cells were cultured with 
2 µg/ml soluble anti-CD28 and 2 µg/ml plate-bound anti-CD3 under 
conditions that induce either Th0 (50 U/ml IL-2; also known as nondif-
ferentiation medium), Th1 (50 U/ml IL-2, 10 ng/ml IL-12, and 1 µg/ml 
anti–IL-4), Th2 (50 U/ml IL-2, 10 ng/ml IL-4, 1 µg/ml anti–IL-12, and 
1 µg/ml anti–IFN-), or Th17 (2 µg/ml anti–IL-2, 1 µg/ml anti–IL-4,   
1 µg/ml anti–IFN-, 20 ng/ml IL-6, and 5 ng/ml TGF-1) cells. 3 d later, 
cells were washed and restimulated with 50 ng/ml PMA and 1 µM ionomycin 
addition to RORT and ROR, are required to activate the 
Il17 gene.
The novel discovery from this work is that c-Rel regu-
lates Th17 response via ROR and RORT. The possibility 
that c-Rel also directly activates the Il17a gene, in addition to 
activating Rorg, cannot be completely ruled out, but is not 
supported by our data. c-Rel failed to activate the Il17a pro-
moter, and was not recruited to it during Th17 differen-
tiation, as we demonstrated in this study. Additionally, we 
searched for putative Rel/NF-B sites between nucleotides 
+1 and 4,000 of the mouse Il17a locus using the Transcrip-
tion Element Search System software, and identified only 
one putative site at 3,629 bp. However, subsequent ChIP 
analysis using anti–c-Rel revealed no binding of c-Rel to this 
site during Th17 differentiation. Therefore, there is no evi-
dence that c-Rel may also bind to the Il17a locus. Similarly, 
because we showed that Stat3 expression was not affected by 
c-Rel deficiency, c-Rel could not regulate Th17 differentia-
tion through Stat3.
Differentiation of autoreactive CD4+ naive T cells into 
Th1 or Th17 effector cells is required for the development of 
autoimmune diseases. Nondifferentiated autoreactive naive 
T  cells  are  not  pathogenic.  Our  observation  that  c-Rel– 
deficient mice are resistant to EAE and T1D indicates that   
c-Rel–mediated T cell differentiation may play a critical role 
in the development of autoimmune diseases (Hilliard et al., 
2002; Lamhamedi-Cherradi et al., 2003). However, because 
c-Rel regulates multiple gene expressions in both lympho-
cytes and myeloid cells (Gerondakis et al., 2006; Bunting   
et al., 2007), the disease resistance of c-Rel–deficient mice 
can be caused by the defect in either lymphoid or myeloid 
cells, or in both. Similarly, c-Rel may regulate Th cell differ-
entiation in vivo through two distinct mechanisms: (1) c-Rel 
expressed  by  T  cells  may  regulate  their  differentiation 
through an autonomous mechanism, e.g., by activating the 
promoters of Th17-specific genes such as Rorg; (2) c-Rel ex-
pressed by myeloid cells may regulate Th cell differentiation 
through a T cell nonautonomous mechanism, e.g., by regu-
lating the expression of cytokines that drive Th17 differentia-
tion. The autonomous theory is supported by the findings 
that (a) purified Rel/ T cells exhibit a significant defect in 
Th17 cell differentiation; (b) c-Rel directly controls the ROR 
and RORT expression; and (c) IL-1, IL-23, and TGF-, 
cytokines  that  promote  Th17  cell  differentiation,  activate 
Rel/NF-B (Shim et al., 2005; Cho et al., 2006; Chung   
et al., 2009). Similarly, the nonautonomous theory is sup-
ported by the finding that the expression of IL-6 and IL-23,   
two cytokines that promote Th17 cell differentiation, is signifi-
cantly reduced in c-Rel–deficient myeloid cells (Lamhamedi- 
Cherradi et al., 2003; Carmody et al., 2007). Interestingly, 
using cDNA microarrays that cover the whole mouse ge-
nome, Bunting et al. (2007) reported that the expression of 
130 genes was reduced in c-Rel–deficient T cells as com-
pared with WT cells treated with anti-CD3 and anti-CD28. 
These genes encode cytokines, chemokines, and cell surface 
molecules, as well as intracellular signal transducers and JEM Vol. 208, No. 11 
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ROR-Rel2-288 mutant, 5-GAATTGCCCTTCTGAAGTGCTGGCAA-
GTCTT-3; RORt-Rel1-166, 5-TAGCTGTGGTTTTGGAATTTT-
CCAACGCCCCCT-3;  RORt-Rel1-166  mutant,  5-TAGCTGTGGTT-
TTAACATTGGATAACGCCCCCT-3; RORt-Rel2-268, 5-GTACTCA-
GGAGAGGGGATTTCGAGCCTGGCCTC-3; RORt-Rel2-268 mutant,   
5-GTACTCAGGAGAGACGATCCCGAGCCTGGCCTC-3.
Promoter luciferase assay. The following DNA fragments were cloned into 
pGL3 luciferase reporter plasmid: the Rorg promoter (0.87 kb) and their mutants, 
the Rorgt promoter (0.55 kb) and their mutants, the Il17a promoter (1.1 kb) with 
or without the Il17a CNS2 (0.9 kb), and the Rora4 promoter (1.1 kb). Site- 
directed mutagenesis of Rel and NFAT binding sites was performed using the 
QuikChange kit (Stratagene), according to manufacturer’s instructions. DNA   
sequencing was used to confirm the mutated nucleotides. To test the promoter 
activity, T cells were transfected with the aforementioned reporter constructs to-
gether with expression plasmids carrying murine c-Rel, p65, p50, RelB, ROR, 
or RORT cDNA using Lipofectamine LTX (Invitrogen) or Amaxa Nucleo-
fector reagents (Lonza). After 24 h, cells were treated with or without 50 ng/ml 
PMA and 1 µM ionomycin for 4–5 h, and the luciferase activities of whole-cell 
lysates were analyzed using the dual-luciferase reporter assay system (Promega). 
Co-transfection with the Renilla-luciferase expression vector pRL-TK (Pro-
mega) was performed in all reporter assays. For all samples, the assays were   
repeated at least three times and the data were normalized for transfection effi-
ciency by dividing firefly luciferase activity by that of the Renilla luciferase.
Statistical analyses. Glucose concentrations, real-time PCR results, and cyto-
kine concentrations were analyzed by Student’s t test. Disease incidence was   
analyzed by Mann-Whitney U test.
Online supplemental material. Fig. S1 shows reduced Th17 response of 
c-Rel–deficient T cells. Fig. S2 shows proliferation and phenotypes of Rel/ 
T cells. Fig. S3 shows defective Th17 differentiation of p65/ T cells. Fig. S4 
shows regulation of the IL-17 gene expression. Fig. S5 shows that enforced 
expression of ROR and RORT did not rescue the proliferation defect of 
Rel/ CD4 T cells. Fig. S6 shows the role of ROR in Th cell differentiation. 
Fig. S7 shows sequence alignment of the human, mouse, and rat Rorg pro-
moter regions. Fig. S8 shows sequence alignment of the human, mouse, and rat 
Rorgt promoter regions. Fig. S9 shows that c-Rel–deficient mice are completely 
resistant to type 1 diabetes. Supplemental materials and methods lists nucleo-
tide sequences. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20110462/DC1.
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